Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study
Research output: Contribution to journal › Journal article › Research › peer-review
Both sublingual allergen-specific immunotherapy (SLIT) and subcutaneous immunotherapy (SCIT) have a documented clinical efficacy, but only few comparative studies have been performed.
Original language | English |
---|---|
Journal | Allergy |
Volume | 59 |
Issue number | 1 |
Pages (from-to) | 45-53 |
Number of pages | 9 |
ISSN | 0105-4538 |
Publication status | Published - Jan 2004 |
- Administration, Sublingual, Adult, Allergens, Anti-Allergic Agents, Betula, Cross-Over Studies, Desensitization, Immunologic, Double-Blind Method, Female, Follow-Up Studies, Humans, Injections, Subcutaneous, Male, Middle Aged, Pollen, Probability, Reference Values, Rhinitis, Allergic, Seasonal, Risk Assessment, Statistics, Nonparametric, Treatment Outcome
Research areas
ID: 50844892